Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.05%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.19 Up 0.06(1.17%) Jul 29, 3:59PM EDT
Prev Close:5.13
Open:5.15
Bid:5.11 x 1100
Ask:5.26 x 4000
1y Target Est:11.63
Beta:1.78
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:5.11 - 5.28
52wk Range:4.60 - 7.84
Volume:1,938,365
Avg Vol (3m):3,406,350
Market Cap:603.74M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXUp 1.17%603.74M
ABTDown 0.42%64.21B
GSKDown 0.35%115.37B
RHHBYDown 0.60%248.35B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):174.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Jun-14) :-0.09
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):0.15

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback